ADVERTISEMENT
Search

Pharmacy News

ISMP issues warning about possible safety issues with newly authorized antiviral

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

New HIV PrEP guidelines call for clinicians to talk with patients about prevention meds

CDC now advises all clinicians to talk to their patients who are sexually active, including adolescents, about HIV preexposure prophylaxis (PrEP) at least once and to prescribe the prevention medication to anyone who requests them.

Autism prevalence higher in CDC’s monitoring network

New data from CDC’s Autism and Developmental Disabilities Monitoring (ADDM) network show that 2.3% of children aged 8 years in 11 communities across the United States had an autism diagnosis in 2018.

New pediatric analysis establishes novel dosing framework for the future

Pharmacists have all heard the phrase “children are not little adults.” It’s popular for a reason: it represents the dangers of simply scaling adult drug dosages to children. Adult physiology, however, has historically been used to scale pediatric dose recommendations.

APhA House of Delegates Virtual Session hears debate and discussion on reviewed policies, Referred Business Item statement

During the Friday, November 5th Virtual Session, the APhA House of Delegates (HOD) received reports from the House Rules Review Committee and from the Policy Review Committee. In addition, the House acted on a Referred Business Item statement from the March 2021 HOD business session held during the 2021 APhA Virtual Annual Meeting & Exposition.

RSS
245678910Last
ADVERTISEMENT